JP Morgan Chase & Co’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $12.8M | Buy |
|
|||||
|
2025
Q1 | $1.44M | Sell |
|
|||||
|
2024
Q4 | $2.35M | Sell |
|
|||||
|
2024
Q3 | $7.98M | Sell |
|
|||||
|
2024
Q2 | $8.25M | Buy |
|
|||||
|
2024
Q1 | $19.8M | Sell |
|
|||||
|
2023
Q4 | $28.7M | Sell |
|
|||||
|
2023
Q3 | $33.2M | Buy |
|
|||||
|
2023
Q2 | $34.5M | Sell |
|
|||||
|
2023
Q1 | $27.5M | Buy |
|
|||||
|
2022
Q4 | $34.6M | Sell |
|
|||||
|
2022
Q3 | $65.9M | Buy |
|
|||||
|
2022
Q2 | $20.7M | Buy |
|
|||||
|
2022
Q1 | $25.5M | Buy |
|
|||||
|
2021
Q4 | $32.3M | Sell |
|
|||||
|
2021
Q3 | $42.3M | Sell |
|
|||||
|
2021
Q2 | $55.4M | Buy |
|